SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-24-032030
Filing Date
2024-03-07
Accepted
2024-03-07 21:40:38
Documents
2
Period of Report
2024-03-04

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm248238-1_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm248238-1_3seq1.xml 3 1567
2 EXHIBIT 24 tm248238d1_ex24.htm EX-24 8255
  Complete submission text file 0001104659-24-032030.txt   11263
Mailing Address 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2RE
Business Address 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2RE 011-44-0-2032834200
Verona Pharma plc (Issuer) CIK: 0001657312 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O VERONA PHARMA PLC 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2RE
Business Address
Fisher Andrew (Reporting) CIK: 0002014301 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38067 | Film No.: 24732176